Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Editor
UK
+4 year(s) experience
HBW Insight
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
Topic Coronavirus OTC Drugs EU
HBW Insight
UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.
HBW Insight
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.
HBW Insight
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
Topic Coronavirus
HBW Insight
In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines and food supplements, according to the AESGP.
Topic Coronavirus
HBW Insight
CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations.
HBW Insight
Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."
HBW Insight
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
HBW Insight
Japan's new Rx-to-OTC switch procedure has exacerbated a "switch lag" compared with developed countries, says Japan Self-Medication Industry senior adviser Toshi Tominaga in an exclusive interview with HBW Insight. Tominaga proposes improvements such as self-care education for consumers and drug usage advice included by firms in switch applications to help balance the risk-benefit decisions of expert judges.
Topic Policy and regulation
HBW Insight
The UK's cannabidiol market, which according to the Cannabis Trades Association is the largest in Europe, awaits clarification on the legal status of CBD-containing food supplements. Meanwhile, major retailers like Walgreen Boots Alliance are stepping into the space with branded products.
HBW Insight
A new position paper by Food Supplements Europe calculates the potential savings that targeted supplementation with omega-3, calcium, phytosterols and vitamins D and B9 could bring for cash-strapped European governments.
HBW Insight
25 Jan 2021
HBW Insight
21 Jan 2021
HBW Insight
15 Jan 2021
HBW Insight
13 Jan 2021
HBW Insight
12 Jan 2021
HBW Insight
11 Jan 2021
HBW Insight
07 Jan 2021
HBW Insight
06 Jan 2021
HBW Insight
05 Jan 2021
HBW Insight
22 Dec 2020
HBW Insight
22 Dec 2020
HBW Insight
21 Dec 2020
HBW Insight
17 Dec 2020
HBW Insight
15 Dec 2020
HBW Insight
08 Dec 2020
